Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 01, 2018 07:25 ET | Source: CURE Pharmaceutical

Prominent Biotech Investor Gene Salkind Adds Another $2M Investment in CURE Pharmaceutical

OXNARD, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, has announced that the company secured a $2 million investment...